| Primary |
| Dementia Alzheimer's Type |
44.7% |
| Dementia |
26.4% |
| Amnesia |
11.1% |
| Memory Impairment |
4.6% |
| Atrial Fibrillation |
1.6% |
| Cognitive Disorder |
1.6% |
| Depression |
1.3% |
| Hypertension |
1.3% |
| Confusional State |
1.0% |
| Parkinson's Disease |
0.9% |
| Migraine |
0.8% |
| Neuropathy Peripheral |
0.7% |
| Parkinsonism |
0.7% |
| Vascular Dementia |
0.7% |
| Nervous System Disorder |
0.5% |
| Pain |
0.5% |
| Aphasia |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Normal Pressure Hydrocephalus |
0.4% |
| Prophylaxis |
0.4% |
|
| Somnolence |
12.6% |
| Dizziness |
10.8% |
| Confusional State |
7.6% |
| Tremor |
7.6% |
| Urinary Tract Infection |
7.6% |
| Convulsion |
6.3% |
| Headache |
4.8% |
| Syncope |
4.8% |
| Weight Decreased |
4.8% |
| Gait Disturbance |
4.0% |
| Diarrhoea |
3.8% |
| Vomiting |
3.8% |
| Insomnia |
3.0% |
| Nausea |
3.0% |
| Rash |
3.0% |
| Vision Blurred |
3.0% |
| Constipation |
2.5% |
| Fatigue |
2.5% |
| Feeling Abnormal |
2.3% |
| Hallucination |
2.3% |
|
| Secondary |
| Dementia Alzheimer's Type |
44.6% |
| Dementia |
23.1% |
| Amnesia |
11.4% |
| Memory Impairment |
3.9% |
| Blood Cholesterol Increased |
2.4% |
| Parkinsonism |
1.8% |
| Cognitive Disorder |
1.7% |
| Depression |
1.6% |
| Hypertension |
1.4% |
| Confusional State |
1.4% |
| Product Used For Unknown Indication |
1.3% |
| Neuropathy Peripheral |
1.0% |
| Convulsion |
0.7% |
| Parkinson's Disease |
0.7% |
| Migraine |
0.6% |
| Aphasia |
0.6% |
| Vascular Dementia |
0.5% |
| Diabetes Mellitus |
0.5% |
| Atrial Fibrillation |
0.5% |
| Hypotension |
0.4% |
|
| Somnolence |
14.0% |
| Dizziness |
10.5% |
| Tremor |
8.2% |
| Urinary Tract Infection |
7.7% |
| Confusional State |
7.2% |
| Weight Decreased |
7.0% |
| Headache |
5.4% |
| Wrist Fracture |
4.0% |
| Syncope |
3.8% |
| Walking Disability |
3.8% |
| Vision Blurred |
3.4% |
| Constipation |
3.2% |
| Fatigue |
3.2% |
| Rash |
3.2% |
| Gait Disturbance |
3.0% |
| Insomnia |
3.0% |
| Vomiting |
2.6% |
| White Blood Cell Count Increased |
2.6% |
| Lethargy |
2.3% |
| Urinary Incontinence |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.5% |
| Dementia Alzheimer's Type |
10.0% |
| Drug Use For Unknown Indication |
9.2% |
| Dementia |
7.1% |
| Hypertension |
6.8% |
| Depression |
5.6% |
| Multiple Sclerosis |
4.5% |
| Pain |
4.0% |
| Osteoporosis |
3.4% |
| Memory Impairment |
3.3% |
| Parkinson's Disease |
2.3% |
| Atrial Fibrillation |
2.2% |
| Anxiety |
2.1% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Supplementation Therapy |
1.8% |
| Diabetes Mellitus |
1.7% |
| Prophylaxis |
1.7% |
| Bipolar Disorder |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Constipation |
1.6% |
|
| Vomiting |
9.8% |
| Urinary Tract Infection |
9.6% |
| Death |
8.7% |
| Somnolence |
7.2% |
| Weight Decreased |
6.7% |
| Weight Increased |
6.1% |
| Pneumonia |
5.2% |
| Drug Ineffective |
5.1% |
| Tremor |
4.5% |
| Fall |
4.4% |
| Syncope |
4.3% |
| Myocardial Infarction |
3.8% |
| Wrong Technique In Drug Usage Process |
3.7% |
| Suicidal Ideation |
3.5% |
| Hypotension |
3.3% |
| Unresponsive To Stimuli |
3.1% |
| Dementia Alzheimer's Type |
2.8% |
| Pyrexia |
2.8% |
| Dementia |
2.7% |
| Cardiac Failure Congestive |
2.6% |
|
| Interacting |
| Hypertension |
23.8% |
| Dementia |
10.4% |
| Prostatic Disorder |
9.3% |
| Dementia With Lewy Bodies |
8.3% |
| Blood Pressure Abnormal |
5.2% |
| Dementia Alzheimer's Type |
5.2% |
| Cardiac Disorder |
4.7% |
| Depression |
4.1% |
| Nervous System Disorder |
3.6% |
| Anxiety |
3.1% |
| Urine Flow Decreased |
3.1% |
| Amnesia |
2.6% |
| Memory Impairment |
2.6% |
| Mineral Supplementation |
2.6% |
| Nervousness |
2.1% |
| Pain |
2.1% |
| Sleep Disorder |
2.1% |
| Vitamin D Decreased |
2.1% |
| Insomnia |
1.6% |
| Vitamin D Deficiency |
1.6% |
|
| Balance Disorder |
16.7% |
| Drug Interaction |
16.7% |
| Syncope |
16.7% |
| Abnormal Behaviour |
12.5% |
| Therapeutic Response Unexpected |
8.3% |
| Vitamin D Decreased |
8.3% |
| Dementia With Lewy Bodies |
4.2% |
| Fall |
4.2% |
| Haemorrhagic Stroke |
4.2% |
| Lethargy |
4.2% |
| Neoplasm Progression |
4.2% |
|
